Is Allovir undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Allovir Inc (ALVR) is -95.45 USD. This Allovir valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.81 USD, the upside of Allovir Inc is -1,072.96%. This means that Allovir is overvalued by 1,072.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -95.45 - -95.45 | -95.45 | -1,072.96% |
| P/E | (599.41) - (939.20) | (725.40) | -7494.5% |
| DDM - Stable | (95.37) - (234.96) | (165.17) | -1783.7% |
| DDM - Multi | (236.60) - (481.06) | (320.06) | -3362.6% |
| Market Cap (mil) | 30.20 |
| Beta | -0.56 |
| Outstanding shares (mil) | 3.08 |
| Enterprise Value (mil) | -88.09 |
| Market risk premium | 4.60% |
| Cost of Equity | 14.66% |
| Cost of Debt | 5.00% |
| WACC | 9.83% |